Retrovirus-mediated Gene Transfer of Rat Glutathione S-Transferase Yc Confers Alkylating Drug Resistance in NIH 3T3 Mouse Fibroblasts

Cancer Research

Volumn 54, Issue 16, 1994, Pages 4442-4447

  Greenbaum, Mona ^a   Létourneau, Sylvain ^a   Assar, Homa ^a   Schecter, Robyn L ^b   Batist, Gerald ^b   Cournoyer, Denis ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CHLORMETHINE; COMPLEMENTARY DNA; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; METHOTREXATE; VIRUS VECTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG RESISTANCE; FIBROBLAST; GENE TRANSFER; GENETIC VARIABILITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMAL; BLOTTING, SOUTHERN; CHLORAMBUCIL; DRUG RESISTANCE; GENETIC VECTORS; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MECHLORETHAMINE; MICE; RATS; RETROVIRIDAE; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0027956024     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Morrow, C.S., and Cowan K.H. Drug resistance and its clinical circumvention. In: J.F. Holland, E. Frei III, R.C. Bast, D.W. Kufe, D.L. Morton, and R.R. Weiselbaum (eds.), Cancer Medicine, pp. 618-631. Malvern, PA: Lea & Febiger, 1993.
2. Roninson, I.B. (ed.). Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. New York: Plenum Publishing Corp., 1991.
3. Gottesman, M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
4. Pommier, Y., Kerrigan, D., Schwartz, R.E., Swack, J.A., and McCurdy, A. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46: 3075-3081, 1986.
5. Glisson, B., Gupta, R., Hodges, P., and Ross, W. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target Cancer Res., 46: 1939-1942, 1986.
6. Beck, W.T., Cirtain, M.C., Danks, M.K., Felsted, R.L., Safa, A.R., Wolverton, J.S., Suttle, D.P., and Trent, J.M. Pharmacological, molecular, and cytogenetic analysis of “atypical” multidrug-resistant human leukemic cells. Cancer Res., 47: 5455-5460, 1987.
7. Deffie, A.M., Batra, J.K., and Goldenberg, G.J. Direct correlation between DNA topoisomerase 11 activity and cytotoxicity in Adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res., 49: 58-62, 1989.
8. Samson, L., Derfler, B., and Waldstein, E.A. Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes. Proc. Natl. Acad. Sci. USA, 83: 5607-5610, 1986.
9. Jelinek, J., Kleibl, K., Dexter, T.M., and Margison, G.P. Transfection of murine multi-potent haematopoietic stem cells with an. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis (Lond.), 9: 81-87, 1988.
10. Kataoka, H., Hall, J., and Karran, P. Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster ovary cells by expression of a cloned bacterial DNA repair gene. EMBO J., 12: 3195-3200, 1986.
11. Dumenco, L.L., Warman, B., Hatzoglou, M., Lim, I.K., Abboud, S.L., and Gerson, S.L. Increased in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine DNA alkyltransferase. Cancer Res., 49: 6044-6051, 1989.
12. Dumenco, L.L., Allay, E., Norton, K., and Gerson, S.L. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science (Washington DC), 259: 219-222, 1993.
13. Bodell, W.J., Aida, T., Berger, M.S., and Rosenblum, M.L. Increased repair of O6-alkylguanine DNA adducts in glioma-derived human cells resistant to cytotoxic. Carcinogenesis (Lond.), 7: 879-883, 1986.
14. Pegg, A.E. Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
15. Coles, B., and Ketterer, B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol., 25: 47-70, 1990.
16. Buller, A.L., Clapper, M.L., and Tew, K.D. Glutathione-5-transferase in nitrogen mustard-resistant and sensitive cell lines. Mol. Pharmacol., 31: 575-578, 1987.
17. Robson, C.N., Lewis, A.D., Wolf, C.R., Hayes, J.D., Hall, A., Proctor, S.J., Harris, A.L., and Hickson, I.D. Reduced levels of drug-induced DNA cross linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione-S-transferase activity. Cancer Res., 47: 6022-6027, 1987.
18. Lewis, A.D., Hickson, I.D., Robson, C.N., Harris, A.L., Hayes, J.D., Griffiths, S.A., Manson, M.M., Hall, A.E., Moss, J.E., and Wolf, C.R. Amplification and increased expression of a class glutathione-S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc. Natl. Acad. Sci. USA, 85: 8511-8515, 1988.
19. Smith, M.T., Evans, C.G., Doane-Setzer, P., Castro, V.M., Tahir, M.K., and Mannervik, B. Denitrosation of l, 3-bis(chloroethyl)-l-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res., 49: 2621-2625, 1989.
20. Schecter, R.L., Woo, A., Duong, M., and Batist, G. In vitro and in vivo mechanisms of drug resistance in a rat mammary carcinoma model. Cancer Res., 57: 1434-1442, 1991.
21. Batist, G., Tupule, A., Sinha, B.K., Kati, A.G., Myers, C.E., and Cowan, K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261: 15544-15549, 1986.
22. Wolf, C.R., Hayward, I.P., Laurie, S.S., Buclon, K., McLntyre, M.A., Adams, D.J., Lewis, A.D., Scott, A.R., and Smyth, J.F. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int. J. Cancer, 39: 695-702, 1987.
23. Mannervick, B., and Jensson, H. Binary combinations of four protein subunits with different catalytic specificities explain the relationship between six basic glutathione 5-transferases in rat liver cytosol. J. Biol. Chem., 257: 9909-9912, 1982.
24. Mannervick, B. The isoenzymes of glutathione transferase. Adv. Enzymol., 57: 357-417, 1985.
25. Tew, K.D., Bomber, A.M., and Hoffman, S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug-resistant and -sensitive cell lines. Cancer Res., 48: 3622-3625, 1988.
26. Clapper, M.L., Hoffman, S.J., and Tew, K.D. Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid. J. Cell Pharmacol., 1: 71-78, 1990.
27. Black, S., Beggs, J.D., and Miles, J.S. Expression of human glutathione transferases in 5. cerevisiae confers resistance to alkylating agents and chlorambucil. Proc. Am. Assoc. Cancer Res., 30: 515, 1989.
28. Miyasaki, M., Khono, K., Saburi, Y., Matsuo, K., Ono, M., Kuwano, M., Tsuchida, S., Sato, K., Sakai, M., and Muramatsu, M. Drug resistance to cis-diamminedichlo-roplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione 5-transferase pi gene. Biochem. Biophys. Res. Commun., 166: 1358-1364, 1990.
29. Puchalski, R.B., and Fahl, W.E. Expression of recombinant glutathione 5-transferase pi, Ya or Yb1 confers resistance to alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 2443-2447, 1990.
30. Schecter, R.L., and Alaoui, M.A. Glutathione 5-transferase in chemotherapy resistance and in carcinogenesis. Biochem. Cell Biol., 70: 349-353, 1992.
31. Schecter, R.L., Alaoui-Jamali, M.A., Woo, A., Fahl, W.E., and Batist, G. Expression of rat glutathione 5-transferase Yc complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Cancer Res., 53: 4900-4906, 1993.
32. Moscow, J.A., Townsend, A.J., and Cowan, K.H. Elevation of pi class glutathione 5-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol. Pharmacol., 36: 22-28, 1989.
33. Moscow, J.A., Fairchild, C.R., Madden, M.J., Ransom, D.T., Wieand, H.S., O'Brien, E.E., Poplack, D.G., Cossman, J., Myers, C.E., and Cowan, K.H. Expression of anionic glutathione-S-tranferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49: 1422-1428, 1989.
34. Leyland-Jones, B.R., Townsend, A.J., Tu, C.D., Cowan, K.H., and Goldsmith, M.E. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human a class glutathione 5-transferase gene. Cancer Res., 57: 587-594, 1991.
35. Waxman, D.J. Glutathione 5-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy-a review. Cancer Res., 50: 6449-6454, 1990.
36. Markowitz, D., Goff, S., and Bank, A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol., 62: 1120-1124, 1988.
37. Markowitz, D., Goff, S., and Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology, 767: 400-406, 1988.
38. Telakowski-Hopkins, C.A., Rodkey, J.A., Bennett, C.D., Lu, A.Y., and Pickett, C.B. Rat liver glutathione 5-transferases. Construction of a cDNA clone complementary to a Yc mRNA and prediction of the complete amino acid sequence of a Yc subunit. J. Biol. Chem., 260: 5820-5825, 1985.
39. Scarpa, M., Cournoyer, D., Muzny, D.M., Moore, K.A., Belmont, J.W., and Caskey, C.T. Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology, 180: 849-852, 1991.
40. Cournoyer, D., Scarpa, M., Mitani, K., Moore, K.A., Markowitz, D., Bank, A., Belmont, J.W., and Caskey, C.T. Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum. Gene Ther., 2: 203-213, 1991.
41. Southern, P.J., and Berg, P. Transformation of mammalian cells to antibiotic resistance by a bacterial gene under control of the SV40 early region promoter. J. Mol. and Appl. Genet., 7: 327-341, 1982.
42. Bodine, D.M., McDonagh, K.T., Brandt, S.J., Ney, P.A., Agricola, B., Byrne, B., and Nienhuis, A.W. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 87: 3738-3742, 1990.
43. Huszar, D., Ellis, J., and Bernstein, A. A rapid and accurate method for determining the titer of rertovirus vectors lacking a selectable marker. Technique, 7: 28-32, 1989.
44. Current Protocols in Molecular Biology. Brooklyn, NY: Greene Publishing Associates, Inc., and John Wiley & Sons, Inc., 1992.
45. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
46. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
47. Habig, W.H., Pabst, M.J., and Jakoby, W.B. Glutathione 5-transferase: the first enzymic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139, 1974.
48. Paglia, D.E., and Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione-peroxidase. J. Lab. Clin. Med., 70: 158-169, 1967.
49. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65: 55-63, 1983.
50. Plumb, J.A., Milroy, R., and Kaye, S.B. Effects of the pH dependence of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49: 4435-4440, 1989.
51. Perucho, M., Hanahan, D., and Wigler, M. Genetic and physical linkage of exogenous sequences in transformed cells. Cell, 22: 309-317, 1980.
52. Belmont, J.W., MacGregor, G.R., Wager-Smith, K., Fletcher, F.A., Moore, K.A., Hawkins, D., Villalon, D., Chang, S.M.W., and Caskey, C.T. Expression of human adenosine deaminase in murine hematopoietic cells. Mol. Cell. Biol., 8: 5116-5125, 1988.
53. Tormey, D., Kline, J., Kalish-Black, D., Love, R., and Carbone, P. Aggressive systemic therapy for metastatic breast cancer. In: F. Ames, G. Blumenschein, and E. Montague (eds.), Current Controversies in Breast Cancer, pp. 273-282. Houston: University of Texas Press, 1984.
54. Peters, W.P. The rationale for high-dose chemotherapy with autologous bone marrow support in treating breast cancer. In: K. Ditke, G. Spitzer, A. Zander (eds.), The First International Symposium on ABMT, pp. 189-195. Houston, TX: The M.D. Anderson Hospital and Tumor Institute, 1985.
55. Chabner, B.A., and Myers, C.E. Clinical pharmacology of cancer chemotherapy. In: V.T. De Vita, S. Hellman, and S.A. Rosenberg (eds.), Cancer: Principle and Practice of Oncology, pp. 349-395. Philadelphia: J.B. Lippincott Company, 1989.
56. Schecter, R.L., Cournoyer, D., and Batist, G. Glutathione 5-transferase expression in mammary tumors and bone marrow cells. Cell. Pharmacol., in press, 1994.